Particulate Detection Monitors
1
–
3
of
3
results
1
2
ATCC PDM-107 (HCM-BROD-0009-C25) patient-derived pancreatic tumor organoid model, cryopreserved vial for research use
PDM-107 (HCM-BROD-0009-C25) is a patient-derived organoid model isolated from metastatic pancreatic adenocarcinoma. Supplied as cryopreserved organoid cultures, it is intended for basic research and pharmacological screening, with handling and culture recommendations provided by the supplier.
- Derived from metastatic pancreatic adenocarcinoma tissue.
- Cryopreserved single-use vial containing ≥ 1.0 x 10^6 viable cells in 1.0 mL.
- Intended for basic research and compound screening applications.
- Store at temperatures below -130°C (liquid nitrogen vapor) until use.
- Culture in 3D extracellular matrix at 37°C in 95% air, 5% CO2.
- Recommended to use basement membrane matrix or Matrigel for ECM support.
- Follow recommended organoid media formulation and handling protocols for initiation and subculture.
- Quality control: tested negative for bacterial, fungal, mycoplasma, and selected viral contaminants.
3
ATCC PDM-108 (HCM-BROD-0010-C25) Human Pancreatic Tumor-Derived Organoid Model, Frozen, BSL-1, Research Use Only
ATCC PDM-108 (HCM-BROD-0010-C25) is a patient-derived organoid model isolated from metastatic pancreatic adenocarcinoma and intended for basic cancer research and pharmacological screening. Supplied frozen and characterized for organoid culture under standard laboratory conditions.
- Derived from human pancreatic adenocarcinoma tissue.
- Organoid culture suitable for 3D assays and pharmacological screening.
- Biosafety level 1 and intended for laboratory research use only.
- Recommended growth at 37°C in 95% air, 5% CO2 atmosphere.
- Seeding density: 0.25-1 x 10^6 viable cells per 100 μL of ECM per well (6-well plate).
- Include 10 μM ROCK inhibitor for the first 2-3 days following subculture.
- Supplied frozen in dry ice packaging; store below -130°C (liquid nitrogen vapor) until use.